bioAffinity Technologies announces 1-for-30 reverse stock split effective Sept 19, 2025

bioAffinity Technologies, Inc.

1-for-30 reverse stock split effective at open of trading on Nasdaq on September 19, 2025.
Post-split outstanding shares approximately 1,338,029; fractional shares paid in cash.
Reverse split intended to bring Company into compliance with Nasdaq minimum bid price requirement.
Proportionate adjustments to exercise prices and shares underlying stock options and warrants.
CUSIP for common stock changes to 09076W307; trading symbol BIAF unchanged.

item 3.03item 5.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.